000 01317 a2200361 4500
005 20250513150559.0
264 0 _c19981006
008 199810s 0 0 eng d
022 _a0736-4679
024 7 _a10.1016/s0736-4679(98)00054-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSagarin, M J
245 0 0 _aDelay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effect.
_h[electronic resource]
260 _bThe Journal of emergency medicine
_c
300 _a557-65 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aElectrocardiography
650 0 4 _aEmergencies
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
_xdiagnosis
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aRetrospective Studies
650 0 4 _aStreptokinase
_xtherapeutic use
650 0 4 _aThrombolytic Therapy
_xmethods
650 0 4 _aTime Factors
650 0 4 _aTissue Plasminogen Activator
_xtherapeutic use
700 1 _aCannon, C P
700 1 _aCermignani, M S
700 1 _aScirica, B M
700 1 _aWalls, R M
773 0 _tThe Journal of emergency medicine
_gvol. 16
_gno. 4
_gp. 557-65
856 4 0 _uhttps://doi.org/10.1016/s0736-4679(98)00054-7
_zAvailable from publisher's website
999 _c9661802
_d9661802